ArticleInternational orthopaedics2026
Epidemiological and clinical review of spinal Tuberculosis at a Regional Orthopaedic Hospital in Nigeria.
Article in International orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSpinal tuberculosis (TB) remains a major cause of morbidity in low- and middle-income countries. This study evaluated the epidemiological profile, management strategies, and neurological outcomes of spinal TB at a tertiary orthopaedic centre in Nigeria.
methodsA retrospective review of patients treated between January 2021 and October 2025 was conducted. Diagnosis was based on clinical, radiological, microbiological, or histopathological criteria. Demographic and neurological data using the ASIA impairment scale were extracted. Changes in neurological status between presentation and final follow-up were analysed using the Wilcoxon signed-rank test, with significance set at p < 0.05.
resultsA total of 223 patients were identified; 61% were male (n = 137) with a mean age of 45.2 years (range 4-81). All patients received anti-tuberculous therapy. Non-operative management was undertaken in 203 patients (91%), while 20 patients (9%) underwent adjunctive surgery for neurological deficit, instability, or deformity. Among conservatively managed patients with documented orthopaedic follow-up (n = 95), 75 presented with neurological deficits; 62 (82.7%) improved by at least one ASIA grade, including 51 (68.0%) who recovered to ASIA E (median improvement D to E; p < 0.001). Twelve surgical patients had neurological deficits; 83.3% improved postoperatively, with 33.3% achieving complete recovery (exact p = 0.002). Surgical complication rate was 15%, with no mortality.
conclusionProtocol-driven spinal TB management combining universal chemotherapy with selective surgery yields favourable neurological outcomes in endemic resource-limited settings.
Indexed as
Identifiers
42126583What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.